Connecting you to content on EBSCOhost

Works by Keller, Stuart Y.

Results: 3

1

Clinical effectiveness and safety of baricitinib for the treatment of juvenile idiopathic arthritis-associated uveitis or chronic anterior antinuclear antibody-positive uveitis: study protocol for an open-label, adalimumab active-controlled phase 3 clinical trial (JUVE-BRIGHT).

Published in:

2021

By:

Ramanan, Athimalaipet V;
Guly, Catherine M;
Keller, Stuart Y;
Schlichting, Douglas E;
de Bono, Stephanie;
Liao, Ran;
Quartier, Pierre

Publication type:

journal article

2

One-Year Clinical Effectiveness Comparison of Prasugrel with Ticagrelor: Results from a Retrospective Observational Study using an Integrated Claims Database.

Published in:

American Journal of Cardiovascular Drugs, 2018, v. 18, n. 2, p. 129, doi. 10.1007/s40256-017-0255-y

By:

Effron, Mark B.;
Nair, Kavita V.;
Molife, Cliff;
Keller, Stuart Y.;
Page, Robert L.;
Simeone, Jason C.;
Murphy, Brian;
Nordstrom, Beth L.;
Zhu, Yajun;
McCollam, Patrick L.;
Vetrovec, George W.

Publication type:

Article

3

A population pharmacokinetic model using allometric scaling for baricitinib in patients with juvenile idiopathic arthritis.

Published in:

CPT: Pharmacometrics & Systems Pharmacology, 2024, v. 13, n. 6, p. 970, doi. 10.1002/psp4.13131

By:

Decker, Rodney L.;
Steven Ernest, C.;
Radtke, David B.;
Wang, Rona;
Araújo, Joana;
Keller, Stuart Y.;
Zhang, Xin

Publication type:

Article